{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:32:05Z","timestamp":1793377925929,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"University of Milan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004702","name":"University of Genoa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.035","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:32:08Z","timestamp":1784388728000},"page":"6086-6110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Federica","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Federica","family":"Tremonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dellacasagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Corsaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Thellung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Barsotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giammarco","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Bajetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pattarozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-996X","authenticated-orcid":false,"given":"Tullio","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.035_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00401-018-1905-0","article-title":"Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma","volume":"136","author":"Stichel","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib3","first-page":"363","article-title":"Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition","volume":"21","author":"Xu","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ymthe.2026.07.035_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer cell"},{"key":"10.1016\/j.ymthe.2026.07.035_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.onc.1209785","article-title":"Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine","volume":"26","author":"Roos","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2026.07.035_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.ymthe.2026.07.035_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2025.105867","article-title":"Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis","volume":"5","author":"Geens","year":"2025","journal-title":"Brain Spine"},{"key":"10.1016\/j.ymthe.2026.07.035_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.drudis.2012.06.001","article-title":"The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells","volume":"17","author":"Florio","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2026.07.035_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167549","article-title":"Cancer stem cells: Masters of all traits","volume":"1871","author":"Leck","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ymthe.2026.07.035_bib11","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/neuonc\/noad076","article-title":"Stem-like signatures in human meningioma cells are under the control of CXCL11\/CXCL12 chemokine activity","volume":"25","author":"Barbieri","year":"2023","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib12","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1007\/s12035-016-0025-x","article-title":"Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas","volume":"54","author":"W\u00fcrth","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/14737175.2015.1051968","article-title":"The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence","volume":"15","author":"Auffinger","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ymthe.2026.07.035_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111789","article-title":"Ruta graveolens, but Not Rutin, Inhibits Survival, Migration, Invasion, and Vasculogenic Mimicry of Glioblastoma Cells","volume":"25","author":"Camerino","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fphar.2016.00477","article-title":"Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy","volume":"7","author":"Yi","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12935-024-03581-1","article-title":"The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt\/beta-catenin pathway to sustain the stem-like phenotype of human glioblastoma cells","volume":"24","author":"Corsaro","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2026.07.035_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/14728222.2024.2433130","article-title":"Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targets","volume":"28","author":"Corsaro","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ymthe.2026.07.035_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/neuonc\/nou145","article-title":"SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of \u201ccancer cells with neural stemness\u201d in a p53-dependent manner","volume":"17","author":"Lee","year":"2015","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/neuonc\/noy028","article-title":"Sprouty2 enhances the tumorigenic potential of glioblastoma cells","volume":"20","author":"Park","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1541-7786.MCR-13-0349","article-title":"BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells","volume":"12","author":"Srikanth","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70599","article-title":"Sohlh1 Modulates the Stemness and Differentiation of Glioma Stem-Like Cells by Inactivation of Wnt\/beta-Catenin Signalling Pathway via SFRP1","volume":"29","author":"Zhi","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymthe.2026.07.035_bib22","doi-asserted-by":"crossref","first-page":"15868","DOI":"10.18632\/oncotarget.7520","article-title":"SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells","volume":"7","author":"Talarico","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2026.07.035_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drudis.2015.09.017","article-title":"Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds","volume":"21","author":"W\u00fcrth","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2026.07.035_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.07.035_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fonc.2019.00135","article-title":"Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity","volume":"9","author":"Barbieri","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib26","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.bbamem.2014.12.012","article-title":"Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets","volume":"1848","author":"Peretti","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2026.07.035_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-025-03577-3","article-title":"Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3beta-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells","volume":"44","author":"Cianci","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib28","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1021\/bi100111c","article-title":"Metamorphic response of the CLIC1 chloride intracellular ion channel protein upon membrane interaction","volume":"49","author":"Goodchild","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2026.07.035_bib29","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.18632\/oncotarget.2617","article-title":"Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current","volume":"5","author":"Gritti","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2026.07.035_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-021-02213-0","article-title":"Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives","volume":"41","author":"Barbieri","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fphar.2018.00899","article-title":"Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability","volume":"9","author":"Barbieri","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41419-025-07636-7","article-title":"Addition of metformin to anti-PD-1\/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients","volume":"16","author":"Amato","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.07.035_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12885-015-1235-8","article-title":"In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors","volume":"15","author":"Barbieri","year":"2015","journal-title":"BMC cancer"},{"key":"10.1016\/j.ymthe.2026.07.035_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217694","article-title":"Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP\/PKG pathway activation","volume":"622","author":"Cai","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.07.035_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1475-2867-14-59","article-title":"Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA","volume":"14","author":"Costa","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ymthe.2026.07.035_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yexcr.2018.01.002","article-title":"In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity","volume":"363","author":"Gatti","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib37","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5966\/sctm.2012-0058","article-title":"Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK","volume":"1","author":"Sato","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.035_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s10020-025-01206-5","article-title":"Metformin reverses 5-FU resistance induced by radiotherapy through mediating folate metabolism in colorectal cancer","volume":"31","author":"Wang","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymthe.2026.07.035_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/126586","article-title":"New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells","volume":"2014","author":"W\u00fcrth","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2026.07.035_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4161\/cc.23050","article-title":"Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt","volume":"12","author":"W\u00fcrth","year":"2013","journal-title":"Cell cycle"},{"key":"10.1016\/j.ymthe.2026.07.035_bib42","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.3390\/ijms25115694","article-title":"Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma","volume":"25","author":"Shah","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib43","series-title":"Goodman & Gilman\u2019s: The Pharmaceutical Basis of Therapeutics","author":"Brunton","year":"2022"},{"key":"10.1016\/j.ymthe.2026.07.035_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69696-7","article-title":"Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors","volume":"14","author":"Balboni","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.035_bib45","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1038\/s41598-018-22054-w","article-title":"Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects","volume":"8","author":"Baldassari","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.035_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114789","article-title":"Metformin loaded Mn(3)O(4)@SiO(2) core-shell nanoparticles for glioblastoma multiforme targeted therapy","volume":"254","author":"Nozhat","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ymthe.2026.07.035_bib47","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/nnm-2017-0386","article-title":"Effect of metformin\/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies","volume":"13","author":"Taghizadehghalehjoughi","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ymthe.2026.07.035_bib48","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1074\/jbc.M308444200","article-title":"The intracellular chloride ion channel protein CLIC1 undergoes a redox-controlled structural transition","volume":"279","author":"Littler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib49","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259704","article-title":"A Zn2+-triggered two-step mechanism of CLIC1 membrane insertion and activation into chloride channels","volume":"135","author":"Varela","year":"2022","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib50","doi-asserted-by":"crossref","first-page":"11674","DOI":"10.1021\/bi801147r","article-title":"Formation of an unfolding intermediate state of soluble chloride intracellular channel protein CLIC1 at acidic pH","volume":"47","author":"Fanucchi","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2026.07.035_bib51","doi-asserted-by":"crossref","first-page":"26003","DOI":"10.1074\/jbc.M203666200","article-title":"Recombinant CLIC1 (NCC27) assembles in lipid bilayers via a pH-dependent two-state process to form chloride ion channels with identical characteristics to those observed in Chinese hamster ovary cells expressing CLIC1","volume":"277","author":"Warton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib52","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1021\/acs.langmuir.7b02872","article-title":"X-ray and Neutron Reflectivity Study Shows That CLIC1 Undergoes Cholesterol-Dependent Structural Reorganization in Lipid Monolayers","volume":"33","author":"Hossain","year":"2017","journal-title":"Langmuir."},{"key":"10.1016\/j.ymthe.2026.07.035_bib53","article-title":"Mechanistic Elucidation of CLIC1 Membrane Insertion via Structural and Dynamic Modulation","author":"Cassar","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.07.035_bib54","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1021\/acs.biochem.6b00080","article-title":"Interaction of Human Chloride Intracellular Channel Protein 1 (CLIC1) with Lipid Bilayers: A Fluorescence Study","volume":"55","author":"Hare","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2026.07.035_bib55","doi-asserted-by":"crossref","first-page":"10887","DOI":"10.1021\/bi2012564","article-title":"Transmembrane extension and oligomerization of the CLIC1 chloride intracellular channel protein upon membrane interaction","volume":"50","author":"Goodchild","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2026.07.035_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2026.113113","article-title":"A cryptic-site ligand stabilizes a non-canonical interface and blocks membrane insertion of the chloride intracellular channel CLIC1","volume":"302","author":"Kuila","year":"2026","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib57","doi-asserted-by":"crossref","first-page":"44993","DOI":"10.1074\/jbc.M107804200","article-title":"Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-A resolution","volume":"276","author":"Harrop","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.podrm.2020.07.005","article-title":"Validation of in-vitro bioassay methods: Application in herbal drug research","volume":"46","author":"Indrayanto","year":"2021","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00221-025-07018-7","article-title":"Glioblastoma induced blood-brain barrier dysfunction via a paracrine mechanism that increases claudin-1 expression","volume":"243","author":"Schweiger","year":"2025","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib60","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s004240050196","article-title":"Blockade of epithelial Na+ channels by triamterenes - underlying mechanisms and molecular basis","volume":"432","author":"Busch","year":"1996","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ymthe.2026.07.035_bib61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/367463a0","article-title":"Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits","volume":"367","author":"Canessa","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.035_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1152\/physrev.00007.2002","article-title":"Epithelial sodium channel\/degenerin family of ion channels: a variety of functions for a shared structure","volume":"82","author":"Kellenberger","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2026.07.035_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbrc.2006.08.043","article-title":"A novel spliced variant of the epithelial Na+ channel delta-subunit in the human brain","volume":"349","author":"Yamamura","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2026.07.035_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbrc.2007.11.177","article-title":"Expression analysis of the epithelial Na+ channel delta subunit in human melanoma G-361 cells","volume":"366","author":"Yamamura","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2026.07.035_bib65","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/mol.104.010850","article-title":"Icilin activates the delta-subunit of the human epithelial Na+ channel","volume":"68","author":"Yamamura","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib66","doi-asserted-by":"crossref","first-page":"C943","DOI":"10.1152\/ajpcell.00019.2012","article-title":"ENaCs and ASICs as therapeutic targets","volume":"302","author":"Qadri","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib67","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1158\/1078-0432.CCR-16-1216","article-title":"Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells","volume":"23","author":"Guillotin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00544601","article-title":"Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line","volume":"20","author":"Schalhorn","year":"1981","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020197","article-title":"Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles","volume":"12","author":"Menezo","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2026.07.035_bib70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.ctm.2023.09.004","article-title":"CLIC1 regulation of cancer stem cells in glioblastoma","volume":"92","author":"Randhawa","year":"2023","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.ymthe.2026.07.035_bib71","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1158\/1535-7163.MCT-17-1223","article-title":"Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G(1)-S Phase Progression in Human Glioblastoma Stem Cells","volume":"17","author":"Peretti","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2026.07.035_bib72","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","first-page":"685","article-title":"Diuretics, 14th Edition","author":"J Jackson","year":"2023"},{"key":"10.1016\/j.ymthe.2026.07.035_bib73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40478-022-01463-z","article-title":"Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma","volume":"10","author":"Zhao","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2026.07.035_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074523","article-title":"Point mutations in the transmembrane region of the clic1 ion channel selectively modify its biophysical properties","volume":"8","author":"Averaimo","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2026.07.035_bib75","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/0113892037358160250205191300","article-title":"Chloride Intracellular Channel 1 Enhances Glioblastoma Cell Migration and Epithelial-Mesenchymal Transition by Activating the ERK1\/2 Signaling Pathway","volume":"26","author":"Zhang","year":"2025","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib76","first-page":"287","article-title":"Drug resistance in glioblastoma: are persisters the key to therapy?","volume":"3","author":"Oliver","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ymthe.2026.07.035_bib77","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1111\/ejn.12007","article-title":"Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain","volume":"36","author":"Nokia","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib78","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.7150\/thno.37023","article-title":"Proliferative regulation of alveolar epithelial type 2 progenitor cells by human Scnn1d gene","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.07.035_bib79","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/jox14040105","article-title":"In Silico Analysis of Triamterene as a Potential Dual Inhibitor of VEGFR-2 and c-Met Receptors","volume":"14","author":"Lutimba","year":"2024","journal-title":"J. Xenobiot."},{"key":"10.1016\/j.ymthe.2026.07.035_bib80","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1074\/jbc.M807111200","article-title":"Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors","volume":"284","author":"Griffero","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4161\/cc.23372","article-title":"Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures","volume":"12","author":"Carra","year":"2013","journal-title":"Cell cycle"},{"key":"10.1016\/j.ymthe.2026.07.035_bib82","doi-asserted-by":"crossref","first-page":"38638","DOI":"10.18632\/oncotarget.9575","article-title":"Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells","volume":"7","author":"Corsaro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2026.07.035_bib83","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.07.035_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005209","article-title":"Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development","volume":"4","author":"Bax","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/j.ymthe.2026.07.035_bib85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fncel.2017.00312","article-title":"Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors","volume":"11","author":"Bajetto","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2026.07.035_bib87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/neu.480260212","article-title":"A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype","volume":"26","author":"McLaurin","year":"1995","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ymthe.2026.07.035_bib88","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1093\/hmg\/ddm270","article-title":"Expansions of CAG.CTG repeats in immortalized human astrocytes","volume":"16","author":"Claassen","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.07.035_bib89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijpharm.2018.09.040","article-title":"Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies","volume":"551","author":"Puech","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ymthe.2026.07.035_bib90","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib91","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jcc.540141112","article-title":"General Atomic and Molecular Electronic-Structure System","volume":"14","author":"Schmidt","year":"1993","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib92","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1021\/jp9717655","article-title":"Application of the RESP Methodology in the Parametrization of Organic Solvents","volume":"102","author":"Fox","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ymthe.2026.07.035_bib93","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ymthe.2026.07.035_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051119","article-title":"Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARgamma Agonist via a Combined Computational and Functional Study","volume":"25","author":"Iannotti","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2026.07.035_bib95","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ymthe.2026.07.035_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241915022","article-title":"Robust AMBER Force Field Parameters for Glutathionylated Cysteines","volume":"24","author":"Elftmaoui","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.07.035_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41419-017-0252-8","article-title":"Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death","volume":"9","author":"Thellung","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.07.035_bib98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ymthe.2026.07.035_bib99","series-title":"The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio)","author":"Westerfield","year":"2000"},{"key":"10.1016\/j.ymthe.2026.07.035_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/acph-2016-0022","article-title":"High performance liquid chromatography for simultaneous determination of xipamide, triamterene and hydrochlorothiazide in bulk drug samples and dosage forms","volume":"66","author":"Abd El-Hay","year":"2016","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ymthe.2026.07.035_bib101","doi-asserted-by":"crossref","first-page":"11.14.1","DOI":"10.1002\/0471250953.bi1114s51","article-title":"Mapping RNA-seq Reads with STAR","volume":"51","author":"Dobin","year":"2015","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.07.035_bib102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC bioinformatics"},{"key":"10.1016\/j.ymthe.2026.07.035_bib103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.ymthe.2026.07.035_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:35:44Z","timestamp":1793374544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":104,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006039"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}